Laboratorios Farmaceuticos ROVI Capital Reinvestment Ratio
Laboratorios Farmaceuticos ROVI capital reinvestment ratio. Laboratorios Farmaceuticos ROVI (ROVI) has a Capital Reinvestment Ratio of 0.24x as of September 2025, meaning it reinvests 0% of its operating cash flow (€73.37 Million) in capital expenditures (€17.62 Million). See cash generation quality of Laboratorios Farmaceuticos ROVI to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Laboratorios Farmaceuticos ROVI (2006–2024)
Capital reinvestment ratio of Laboratorios Farmaceuticos ROVI from 2006 to 2024. This chart tracks Laboratorios Farmaceuticos ROVI's Capital Reinvestment Ratio across 18 annual periods. See ROVI FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Laboratorios Farmaceuticos ROVI Capital Reinvestment Ratio by Year (2006–2024)
Laboratorios Farmaceuticos ROVI capital reinvestment ratio by year from 2006 to 2024. For the full cash flow conversion analysis, see ROVI cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.45x | €138.28 Million | €62.22 Million | ▼ -7.7% |
| 2023 | 0.49x | €113.25 Million | €55.19 Million | ▲ +125.3% |
| 2022 | 0.22x | €237.60 Million | €51.39 Million | ▼ -21.1% |
| 2021 | 0.27x | €149.44 Million | €40.94 Million | ▼ -67.6% |
| 2020 | 0.85x | €46.88 Million | €39.69 Million | ▼ -72.7% |
| 2018 | 3.10x | €8.53 Million | €26.46 Million | ▲ +180.5% |
| 2017 | 1.11x | €18.04 Million | €19.94 Million | ▲ +178.5% |
| 2016 | 0.40x | €45.53 Million | €18.08 Million | ▼ -41.4% |
| 2015 | 0.68x | €29.39 Million | €19.90 Million | ▼ -37.8% |
| 2014 | 1.09x | €23.00 Million | €25.05 Million | ▲ +31.6% |
| 2013 | 0.83x | €29.82 Million | €24.68 Million | ▲ +18.3% |
| 2012 | 0.70x | €19.61 Million | €13.72 Million | ▲ +6.2% |
| 2011 | 0.66x | €12.68 Million | €8.35 Million | ▲ +150.3% |
| 2010 | 0.26x | €21.19 Million | €5.58 Million | ▼ -15.2% |
| 2009 | 0.31x | €9.62 Million | €2.99 Million | ▼ -59.6% |
| 2008 | 0.77x | €12.66 Million | €9.74 Million | ▼ -92.5% |
| 2007 | 10.19x | €1.15 Million | €11.73 Million | ▲ +1846.2% |
| 2006 | 0.52x | €7.72 Million | €4.04 Million | — |